Rehmann Capital Advisory Group’s BioTelemetry, Inc. BEAT Stock Holding History

Rehmann Capital Advisory Group’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.34K	Hold	33	–	–	﹤0.01%	1497
2019 Q2	$1.59K	Hold	33	–	–	﹤0.01%	1829
2019 Q1	$2.07K	Hold	33	–	–	﹤0.01%	1760
2018 Q4	$1.97K	Hold	33	–	–	﹤0.01%	1468
2018 Q3	$2.13K	Hold	33	–	–	﹤0.01%	1788
2018 Q2	$1.49K	Sell	33 -26	-44%	-$1.04K	﹤0.01%	1874
2018 Q1	$2K	Buy	+59	New	+$1.94K	﹤0.01%	1817

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Rehmann Capital Advisory Group's BEAT Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its BioTelemetry, Inc. (BEAT) position steady in Q3 2019 at 33 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Rehmann Capital Advisory Group first reported a position in BEAT in Q1 2018 and has held it in 7 quarters since. The position peaked at $2.13K in Q3 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

Rehmann Capital Advisory Group held 33 shares of BioTelemetry, Inc. worth $1.34K as of Q3 2019.
Rehmann Capital Advisory Group left its BioTelemetry, Inc. share count unchanged in Q3 2019.
BioTelemetry, Inc. made up ﹤0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #1497 holding.
Rehmann Capital Advisory Group first reported a position in BioTelemetry, Inc. in Q1 2018 and has held it in 7 quarters since.
Rehmann Capital Advisory Group's BioTelemetry, Inc. position peaked at $2.13K in Q3 2018.
219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.